United Kingdom to India: Kit Import Trade Route

The United Kingdom to India Kit corridor is one of India's established pharmaceutical import routes from United Kingdom, with 600 shipments documented worth a combined $2.1M USD. The route is dominated by ALMAC CLINICAL SERVICES., which alone accounts for roughly 51% of all import value, reflecting the consolidated nature of United Kingdom's kit export sector.

Across 36 active United Kingdom suppliers, the average shipment value stands at $3.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with kit's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 19.2%, placing it at rank #12 among India's top kit import origins globally.

On the Indian buyer side, key Indian importers include CURATEQ BIOLOGICS PRIVATE LIMITED, NULIFE CONSULTANTS AND DISTRIBUTORS PRIVATE LIMITE, ALLIED SCIENTIFIC PRODUCTS., and 27 others. CURATEQ BIOLOGICS PRIVATE LIMITED is the single largest Indian importer with 4 shipments valued at $1.5M USD.

India's kit imports from United Kingdom are driven primarily by a handful of large-scale United Kingdom manufacturers. ALMAC CLINICAL SERVICES. with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 36 active exporters signals a competitive but concentrated market — Indian buyers benefit from United Kingdom supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ALMAC CLINICAL SERVICES., ALMAC CLINICAL SERVICES , ABCAM PLC — together account for 76% of total trade value on this route. The average shipment value of $3.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical for clinical trial only ncv foc blinded kits with bp11 omalizumab or xolair omalizumab 300mg or xpharmaceutical for clinical trial only and pharmaceutical for clinical trial only- (ncv-foc) blinded kits with bp11(omalizumab) or xolair@ (omalizumab) 300mg or xpharmaceutical for clinical trial only-, suggesting that Indian buyers tend to consolidate orders across related product lines from the same United Kingdom supplier.

On the buying side, CURATEQ BIOLOGICS PRIVATE LIMITED is the largest importer with 4 shipments worth $1.5M USD — representing 69% of all kit imports from United Kingdom on this route. A total of 30 buyers are active on this corridor.